Abstract
A ligand of N-2-(furylmethyl iminodiacetic acid) (FMIDA) has been easily labeled by a tetradentate chelating agent of [99mTc]. Factors like a stannous chloride solution as a reducing agent (100 μg), substrate amount (100 μg), pH (7), in vitro stability (8 h) and temperature (37 °C) have been systematically studied to optimize high radiochemical yield (98.0%). The radiochemical conversion was calculated on thin-layer chromatography, paper electrophoresis, and high performance liquid chromatography. Biodistribution study showed that this complex was removed from the kidneys and bladder path way during 1 h post injection. Therefore, [99mTc]FMIDA may be used as renal function radiotracer.
Similar content being viewed by others
References
Hosain F, Reba RC, Wagner HN Jr (1969) Int J Appl Radiat Isot 20:517–521
Bianchi C (1972) Prog Nucl Med 2:21–53
Skov PE (1970) Acta Med Scand 187:419–428
Richards P, Atkins HL (1976) J Nucl Med 7:165–170
Mohini B, Drishty S, Sweety S, Haladhar DS, Meera V, Sharmila B (2012) Curr Radiopharm 5:65–70
Malgorzata L, Jeffrey K, Dinesh S, Jonathon AN, Hyunsuk S, Andrew TT (2014) Nucl Med Biol 41:248–253
Malgorzata L, Jeffrey K, Luigi G, Marzilli A, Taylor T (2012) J Nucl Med 53(8):1277–1283
Yoshiharu K, Koji I, Jiro T (1999) Ann Nucl Med 13(2):127–132
Andrew TT, Malgorzata L, Luigi GM (2010) J Nucl Med 51(3):391–396
Jeffrey K, Malgorzata L, Andrew TT, Luigi GM (2012) Eur J Inorg Chem. https://doi.org/10.1002/ejic.201200599
Klingensmith WC, Fritzberg AR, Spitzer VM et al (1984) J Nucl Med 25:42–48
Taylor A, Eshima D, Alazraki N (1987) Eur J Nucl Med 12(10):510–514
González A, Jover L, Mairal LI, Martin-Comin J, Puchal R (1994) Nuklearmedizin 33(6):244–247
Kramer W, Baum RP, Scheuermann E, Hör G, Jonas D (1993) Urol A (in German) 32(2):115–120
Li Y, Russell CD, Palmer-Lawrence J, Dubovsky EV (1994) J Nucl Med 35(5):846–850
Al-Nahhas AA, Jafri RA, Britton KE et al (1988) Eur J Nucl Med 14(9–10):453–462
O’Malley JP, Ziessman HA, Chantarapitak N (1993) Clin Nucl Med 18:22–29
Shattuck LA, Eshima D, Taylor A et al (1994) J Nucl Med 35:349–355
Brandoni A, Anzai N, Kanai Y, Endou H, Torres AM (2006) Biochim Biophys Acta 1762(7):673–682
Flannery A, Veber J (1980) A literature review. Med Phys 7:249–250
Eshima D, Taylor A (1992) Sem Nucl Med 22:61–73
Esteves FP, Taylor A, Manatunga A, Folks R, Krishnan M, Garcia EV (2006) Am J Roentgenol 187:W610–W617
Alberto R, Abram U (2011) Handbook of nuclear chemistry. Springer, New York, pp 2073–2120
Motaleb MA, El-Said H, Abdallah M, Atef M (2012) Radiochemistry 54(5):501–505
Chen X, Guo Y, Zhang Q, Hao G, Jia H, Liu B (2008) Organomet. Chem. 693:1822–1828
Zhuang ZP, Kung MP, Hou C, Plössl K, Kung HF (2005) Nucl Med Bio 32:171–184
Malgorzata L, Luigi GM, Andrew TT (2009) J Nucl Med 50(3):454–460
Drishty S, Ketaki B, Archana M, Sharmila B, Kanchan K, Meera V (2006) Appl Radiat Isot 64:888–892
Sanad MH, Salama DH, Marzook FA (2017) Radiochim Acta 105(5):389–398
Sanad MH, Gehan MS, Marzook FA (2017) J Label Compd Radiopharm. https://doi.org/10.1002/jlcr.3541
Rhodes BA (1974) Semin Nucl Med 4:281–293
Sanad MH (2013) Radiochemistry 55(5):539–544
Sanad MH, Challan SB (2017) Radiochemistry 59(3):307–312
Sanad MH, Talaat HM (2017) Radiochemistry 59(4):396–401
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sanad, M.H., Ibrahim, A.A. & Talaat, H.M. Synthesis, bioevaluation and gamma scintigraphy of 99mTc-N-2-(furylmethyl iminodiacetic acid) complex as a new renal radiopharmaceutical. J Radioanal Nucl Chem 315, 57–63 (2018). https://doi.org/10.1007/s10967-017-5617-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-017-5617-z